Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model
Journal of Nephropharmacology · 09.08.2025 · 15 (1) · e12805
DOI: 10.34172/npj.2025.12805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephropharmacology, online erschienen am 09.08.2025. Verfasst von Fuad Yusir Mammadov und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Paracetamol overdose is a primary cause of acute liver and renal damage due to oxidative stress and depletion of glutathione reserves. Palladium-Mexidol complexes have demonstrated significant antioxidant, membrane-protective, and cytoprotective properties.
Objectives
This study investigates the therapeutic potential of a palladium–Mexidol complex in this context. Materials and Methods: This experimental animal study was conducted on 36 healthy white rats, randomly divided into four groups. The groups included a healthy control group, a paracetamol-induced hepatitis model group, a treatment group that received intraperitoneal palladium–Mexidol following hepatitis induction, and a post-treatment group assessed ten days after the final dose. Serum levels of hepatic and cellular injury markers, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), creatine phosphokinase (CPK), and alkaline phosphatase (ALP), were measured and compared between each pair of experimental groups Results: The results indicated that the liver enzyme activities showed distinct changes across experimental groups, with healthy control rats maintaining normal levels of AST, ALT, ALP, GGT, LDH, and CPK. Paracetamol-induced hepatitis caused significant elevations in all these enzymes, reflecting liver injury. Treatment with palladium-Mexidol partially normalized enzyme levels, indicating initial recovery, and by the tenth-day post-treatment, further significant improvements were observed, with continued reductions in enzyme concentrations.
Conclusion
The result indicated the hepatoprotective efficacy of the palladium-Mexidol complex in mitigating paracetamol-induced liver toxicity, with progressive improvement observed by the tenth day post-treatment, indicating both immediate hepatoprotection and sustained liver recovery. We conclude that palladium-Mexidol complex is a promising hepatoprotective therapeutic approach that warrants further investigation and assessment of long-term safety profiles to advance its potential clinical applications.
Zitieren
APA
Mammadov, F. Y., Polukhova, S. M., Abaszade, Z. A., Alkishiev, K. S., Khidirova, H. F., Abbasova, M. R., & Kazimli, A. V. (2025). Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model. Journal of Nephropharmacology, 15(1), e12805. https://doi.org/10.34172/npj.2025.12805
Vancouver
Mammadov FY, Polukhova SM, Abaszade ZA, Alkishiev KS, Khidirova HF, Abbasova MR, et al. Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model. Journal of Nephropharmacology. 2025;15(1):e12805. doi:10.34172/npj.2025.12805
BibTeX
@article{Mammadov2025,
author = {Mammadov, Fuad Yusir and Polukhova, Shahzada Musa and Abaszade, Zumrud Amirgulu and Alkishiev, Kamil Sahib and Khidirova, Hijran Faramaz and Abbasova, Maryam Rauf and Kazimli, Aygun Vugar},
title = {Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model},
journal = {Journal of Nephropharmacology},
year = {2025},
volume = {15},
number = {1},
pages = {e12805},
doi = {10.34172/npj.2025.12805}
}
EUVIMED